No. |
Variant name |
Chromosome position |
Chromatin state |
Related regulatory elements |
Target genes |
Extended variants |
Associated traits |
1 |
rs529371699 |
chr2:52960367-52960368 |
Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
2 |
rs113532836 |
chr2:52960472-52960473 |
Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
3 |
rs549048454 |
chr2:52960482-52960483 |
Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
4 |
rs145710994 |
chr2:52960484-52960485 |
Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
5 |
rs183284938 |
chr2:52960519-52960520 |
Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
6 |
rs373143962 |
chr2:52960571-52960572 |
Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
7 |
rs148941476 |
chr2:52960574-52960575 |
Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
8 |
rs545519237 |
chr2:52960619-52960620 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
9 |
rs7592833 |
chr2:52960639-52960640 |
Weak transcription Enhancers
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
10 |
rs552714821 |
chr2:52960641-52960642 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
11 |
rs566440316 |
chr2:52960703-52960704 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
12 |
rs2626390 |
chr2:52960727-52960728 |
Weak transcription Enhancers
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
13 |
rs187456703 |
chr2:52960745-52960746 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
14 |
rs191336800 |
chr2:52960748-52960749 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
15 |
rs544067448 |
chr2:52960766-52960767 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
16 |
rs375728655 |
chr2:52960794-52960795 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
17 |
rs547449539 |
chr2:52960885-52960886 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
18 |
rs561787203 |
chr2:52960887-52960888 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
19 |
rs557896772 |
chr2:52960950-52960951 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
20 |
rs73931435 |
chr2:52960964-52960965 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
21 |
rs540493998 |
chr2:52960993-52960994 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
22 |
rs560131726 |
chr2:52961013-52961014 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
23 |
rs143814450 |
chr2:52961030-52961031 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
24 |
rs184592262 |
chr2:52961117-52961118 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
25 |
rs562629529 |
chr2:52961118-52961119 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
26 |
rs531650522 |
chr2:52961145-52961146 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
27 |
rs189230722 |
chr2:52961170-52961171 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
28 |
rs571782927 |
chr2:52961198-52961199 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
29 |
rs527991247 |
chr2:52961202-52961203 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
30 |
rs548055537 |
chr2:52961221-52961222 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
31 |
rs566504014 |
chr2:52961252-52961253 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
32 |
rs138496375 |
chr2:52961258-52961259 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
33 |
rs555542627 |
chr2:52961262-52961263 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
34 |
rs530855854 |
chr2:52961277-52961278 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
35 |
rs192633182 |
chr2:52961282-52961283 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
36 |
rs537902974 |
chr2:52961290-52961291 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
37 |
rs544040920 |
chr2:52961298-52961299 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
38 |
rs76865820 |
chr2:52961305-52961306 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
39 |
rs77282924 |
chr2:52961312-52961313 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
40 |
rs533869690 |
chr2:52961371-52961372 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
41 |
rs78822428 |
chr2:52961389-52961390 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
42 |
rs553645179 |
chr2:52961394-52961395 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
43 |
rs1840321 |
chr2:52961407-52961408 |
Enhancers Weak transcription
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
mRNA abundance
|
44 |
rs542619047 |
chr2:52961443-52961444 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
45 |
rs562495026 |
chr2:52961489-52961490 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
46 |
rs576482437 |
chr2:52961497-52961498 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
47 |
rs545448968 |
chr2:52961557-52961558 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
48 |
rs565371958 |
chr2:52961577-52961578 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
49 |
rs527864680 |
chr2:52961594-52961595 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
50 |
rs13419330 |
chr2:52961597-52961598 |
Enhancers Weak transcription
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|